ATLAS: A phase II, open-label study of rucaparib in patients (pts) with locally advanced (unresectable) or metastatic urothelial carcinoma

Autor:	Sumati Gupta, Kenton Wride, Alejo Rodriguez-Vida, Petros Grivas, Yousef Zakharia, Debra H. Josephs, Y. Loriot, Daleen Thomas, Andrea Necchi, Simon Chowdhury, A. Loehr, Susan Feyerabend, Dale L. Nepert, S. Srinivas, Andrew Simmons
Rok vydání:	2018
Předmět:	medicine.medical_specialty Metastatic Urothelial Carcinoma business.industry Locally advanced Hematology chemistry.chemical_compound medicine.anatomical_structure Oncology chemistry Open label study Atlas (anatomy) Medicine In patient Radiology business Rucaparib
Zdroj:	Annals of Oncology. 29:viii330
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy283.137
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::049d55a4812514c68f616c3b36d5e1a1 https://doi.org/10.1093/annonc/mdy283.137 Zobrazit plný text záznamu